Low-Dose Psilocybin Therapy for Palliative Care Patients With Chronic Cancer Pain Requiring Opioids

Phase: PHASE2 | Sponsor: Roswell Park Cancer Institute | Compound: Psilocybin

Status

planned

Institution

Roswell Park Cancer Institute

Start date

2025-11-15

End date

2027-05-05

Registry ID

NCT06827054

View trial record

Tracked by the DMT Code Clinical Trials Observatory, an open record of DMT-related clinical research.